Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €108k.
Filing timeline
BuySaleRamy Riad Ahmed Ibrahim
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Ramy Riad Ahmed Ibrahim: trading record in brief
Ramy Riad Ahmed Ibrahim discloses dealings in Takeda Pharmaceutical Co Ltd to SEC (Form 4). We count 2 filings; the first trade dates from 1 July 2026 and the latest from 10 August 2026.
Sales make up the whole of the open-market record (1 sale, €108k). Other entries cover 1 share grant.
Most recently, on 12 August 2026, the filings show an open-market sale worth €108k in Takeda Pharmaceutical Co Ltd. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ramy Riad Ahmed Ibrahim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
7,277 shares@ US$17.100.0002% mcap100.0% of flowAmerican Depositary SharesSEC:0001493152-26-037514:0
25,078 shares0American Depositary SharesSEC:0001395064-26-000256:0
2 of 2 declarations
